The central hypothesis is that serum cystatin C levels are significantly elevated in CKD compared to healthy controls and demonstrate a stronger correlation with estimated GFR (eGFR) than creatinine, thereby offering superior potential for early detection of renal dysfunction. Here, CST3 is linked to chronic kidney disease.